Own the Few
Own the Best
Discover the power of our concentrated growth investment strategy
No data was found
Sands Capital exists to add value and enhance the wealth of our clients with prudence over time.
Singular Focus on Growth
Our strategies selectively allocate capital to leading public and private businesses, across the growth spectrum, around the world.
Cultivating Enduring Partnerships
Our skilled professionals are dedicated to delivering on our mission of adding value, while cultivating deep and enduring partnerships with our clients.
Events
Sands Capital Leads Cytovale’s Series D Funding
Sands Capital led Cytovale’s $100 million Series D funding round, enabling commercial and operational expansion of IntelliSep, a rapid diagnostic test cleared by the Federal Drug Administration (FDA), that is transforming sepsis care for hospital emergency departments and health systems nationwide.
Announcements
Sands Capital Co-leads Anduril Industries’ Series F Funding to Hyperscale Defense Manufacturing
This latest funding will help enable the company’s continued growth, enhanced processes, upgraded tooling, expanded infrastructure, and increased supply chain resiliency.
In The News
Sands Capital Retains UK Stewardship Code Signatory Status
The United Kingdom’s Financial Reporting Council has named Sands Capital as a signatory to the UK Stewardship Code for the second year in a row. The UK Stewardship Code was designed to strengthen reporting requirements and stewardship expectations for asset managers, asset owners, and service providers.